Photon Health: Revolutionizing the $700B Prescription Industry

The prescription industry is broken. In an era where we can order anything with a tap, track our packages in real-time, and compare prices instantly, getting medications remains stuck in the past. Long lines, drug shortages, and opaque pricing continue to plague millions of Americans. This is why we’re thrilled to announce our investment in Photon Health, alongside Notation, Flare Capital, and other strategic partners in their $9M funding round.

Photon Health isn’t just another healthcare startup – it’s a fundamental reimagining of how prescriptions should work. Founded by Otto Sipe, Michael Rado, and Sam Kotlove, the company brings deep expertise from Microsoft, Wayfair, and Thirty Madison.

Their vision? To put prescription control back where it belongs – in the hands of patients.

The company’s growth trajectory speaks volumes. From their Brooklyn headquarters, they’ve built one of America’s largest prescription networks, processing over 70,000 prescriptions monthly. But what truly sets Photon apart is their consumer-first approach. They’ve created a seamless digital experience that gives patients unprecedented control over their prescriptions while saving valuable time for healthcare providers.

What makes Photon particularly compelling is their elegant solution to a complex problem. When a doctor writes a prescription, patients receive a secure link via text message. No apps to download, no complicated portals to navigate. Patients can choose their preferred pharmacy, whether it’s Amazon, their local independent pharmacy, or a major chain like Walgreens. It’s prescription fulfillment reimagined for the digital age.

The impact is already evident. Sesame, a major healthcare marketplace, reported a 71% decrease in prescription support requests after implementing Photon. This efficiency isn’t just about convenience – it’s about fundamentally improving healthcare delivery and patient outcomes.

Looking ahead, Photon is positioned to transform the $700 billion prescription industry. Their platform will soon display medication prices and delivery estimates before pharmacy selection, bringing unprecedented transparency to prescription fulfillment. They’re not just building a better prescription service; they’re creating the future of how medications reach patients.

We’re investing in Photon because they’re tackling one of healthcare’s most persistent challenges with a solution that’s both ambitious and elegantly simple. In a market dominated by legacy systems and entrenched interests, Photon is proving that patient-centered innovation isn’t just possible – it’s inevitable.